{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:37:16Z","timestamp":1790487436999,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,23]]},"DOI":"10.7759\/cureus.15860","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T14:41:45Z","timestamp":1624459305000},"source":"Crossref","is-referenced-by-count":1,"title":["Psoriasis: To Vaccinate or Not to Vaccinate?"],"prefix":"10.7759","author":[{"given":"Christian","family":"Summa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M","family":"Kesselman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Demory Beckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12771","article-title":"Psoriasis and suicidality: a review of the literature","volume":"32","author":"Liang SE","year":"2019","unstructured":"Liang SE, Cohen JM, Ho RS. Psoriasis and suicidality: a review of the literature. Dermatol Ther. 2019, 32:e12771. 10.1111\/dth.12771","journal-title":"Dermatol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/258430","article-title":"Possible triggering effect of influenza vaccination on psoriasis","volume":"2015","author":"Gunes AT","year":"2015","unstructured":"Gunes AT, Fetil E, Akarsu S, Ozbagcivan O, Babayeva L. Possible triggering effect of influenza vaccination on psoriasis. J Immunol Res. 2015, 2015:258430. 10.1155\/2015\/258430","journal-title":"J Immunol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65109-7","article-title":"Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis","volume":"155","author":"Nickoloff BJ","year":"1999","unstructured":"Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol. 1999, 155:145-58. 10.1016\/S0002-9440(10)65109-7","journal-title":"Am J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes JE","year":"2018","unstructured":"Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis. J Immunol. 2018, 201:1605-13. 10.4049\/jimmunol.1800013","journal-title":"J Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.03.017","article-title":"A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: from the medical board of the National Psoriasis Foundation","volume":"81","author":"Baumrin E","year":"2019","unstructured":"Baumrin E, Van Voorhees A, Garg A, Feldman SR, Merola JF. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2019, 81:102-10. 10.1016\/j.jaad.2019.03.017","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1912-5","article-title":"Staphylococcus aureus bacteremia with iliac artery endarteritis in a patient receiving ustekinumab","volume":"16","author":"Joost I","year":"2016","unstructured":"Joost I, Steinfurt J, Meyer PT, Kern WV, Rieg S. Staphylococcus aureus bacteremia with iliac artery endarteritis in a patient receiving ustekinumab. BMC Infect Dis. 2016, 16:586. 10.1186\/s12879-016-1912-5","journal-title":"BMC Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.07.019","article-title":"Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2)","volume":"56","author":"Graves JE","year":"2007","unstructured":"Graves JE, Nunley K, Heffernan MP. Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2). J Am Acad Dermatol. 2007, 56:e55-79. 10.1016\/j.jaad.2006.07.019","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes MA","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014, 32:227-55. 10.1146\/annurev-immunol-032713-120225","journal-title":"Annu Rev Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-010-1065-0","article-title":"Evidence for the presence of bacteria in the blood of psoriasis patients","volume":"302","author":"Munz OH","year":"2010","unstructured":"Munz OH, Sela S, Baker BS, Griffiths CE, Powles AV, Fry L. Evidence for the presence of bacteria in the blood of psoriasis patients. Arch Dermatol Res. 2010, 302:495-8. 10.1007\/s00403-010-1065-0","journal-title":"Arch Dermatol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq183","article-title":"Vaccinations in patients with immune-mediated inflammatory diseases","volume":"49","author":"Rahier JF","year":"2010","unstructured":"Rahier JF, Moutschen M, Van Gompel A, et al.. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford). 2010, 49:1815-27. 10.1093\/rheumatology\/keq183","journal-title":"Rheumatology (Oxford)"},{"key":"ref11","article-title":"Translating the 2019 AAD-NPF guidelines of care for the management of psoriasis with biologics to clinical practice","volume":"104","author":"Pithadia DJ","year":"2019","unstructured":"Pithadia DJ, Reynolds KA, Lee EB, Wu JJ. Translating the 2019 AAD-NPF guidelines of care for the management of psoriasis with biologics to clinical practice. Cutis. 2019, 104:12-6.","journal-title":"Cutis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.12010","article-title":"Influenza vaccination rate among patients with moderate to severe psoriasis","volume":"11","author":"Radtke MA","year":"2013","unstructured":"Radtke MA, Rustenbach SJ, Reusch M, Str\u00f6mer K, Augustin M. Influenza vaccination rate among patients with moderate to severe psoriasis. J Dtsch Dermatol Ges. 2013, 11:837-44. 10.1111\/ddg.12010","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000362808","article-title":"National survey of psoriasis flares after 2009 monovalent H1N1\/seasonal vaccines","volume":"229","author":"Sbidian E","year":"2014","unstructured":"Sbidian E, Eftekahri P, Viguier M, et al.. National survey of psoriasis flares after 2009 monovalent H1N1\/seasonal vaccines. Dermatology. 2014, 229:130-5. 10.1159\/000362808","journal-title":"Dermatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2017-0014","article-title":"Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis","volume":"18","author":"Ovejero-Benito MC","year":"2017","unstructured":"Ovejero-Benito MC, Prieto-P\u00e9rez R, Llamas-Velasco M, et al.. Polymorphisms associated with etanercept response in moderate-to-severe plaque psoriasis. Pharmacogenomics. 2017, 18:631-8. 10.2217\/pgs-2017-0014","journal-title":"Pharmacogenomics"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.62754","article-title":"Biological therapy of psoriasis","volume":"55","author":"Sivamani RK","year":"2010","unstructured":"Sivamani RK, Correa G, Ono Y, Bowen MP, Raychaudhuri SP, Maverakis E. Biological therapy of psoriasis. Indian J Dermatol. 2010, 55:161-70. 10.4103\/0019-5154.62754","journal-title":"Indian J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.040","article-title":"Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept","volume":"65","author":"Lynde C","year":"2011","unstructured":"Lynde C, Krell J, Korman N, Mathes B. Immune response to pneumococcal polysaccharide vaccine in adults with chronic plaque psoriasis treated with alefacept. J Am Acad Dermatol. 2011, 65:799-806. 10.1016\/j.jaad.2010.04.040","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.7304","article-title":"Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases","volume":"308","author":"Zhang J","year":"2012","unstructured":"Zhang J, Xie F, Delzell E, et al.. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. JAMA. 2012, 308:43-9. 10.1001\/jama.2012.7304","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.39670","article-title":"Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination","volume":"68","author":"Yun H","year":"2016","unstructured":"Yun H, Yang S, Chen L, et al.. Risk of herpes zoster in autoimmune and inflammatory diseases: implications for vaccination. Arthritis Rheumatol. 2016, 68:2328-37. 10.1002\/art.39670","journal-title":"Arthritis Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/art.40189","article-title":"Herpes zoster and tofacitinib: clinical outcomes and the risk of concomitant therapy","volume":"69","author":"Winthrop KL","year":"2017","unstructured":"Winthrop KL, Curtis JR, Lindsey S, et al.. Herpes zoster and tofacitinib: clinical outcomes and the risk of concomitant therapy. Arthritis Rheumatol. 2017, 69:1960-8. 10.1002\/art.40189","journal-title":"Arthritis Rheumatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2016.1134481","article-title":"The herpes zoster subunit vaccine","volume":"16","author":"Cunningham AL","year":"2016","unstructured":"Cunningham AL. The herpes zoster subunit vaccine. Expert Opin Biol Ther. 2016, 16:265-71. 10.1517\/14712598.2016.1134481","journal-title":"Expert Opin Biol Ther"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsi.2012.03.001","article-title":"New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette-Guerin","volume":"30","author":"Hung CT","year":"2012","unstructured":"Hung CT, Wang WM, Tsao CW, Chiang CP. New-onset guttate psoriasis following intravesical immunotherapy of Bacillus Calmette-Guerin. Dermatol Sin. 2012, 30:108-11. 10.1016\/j.dsi.2012.03.001","journal-title":"Dermatol Sin"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0496","article-title":"Psoriatic skin lesions induced by BCG vaccination","volume":"88","author":"Takayama K","year":"2008","unstructured":"Takayama K, Satoh T, Hayashi M, Yokozeki H. Psoriatic skin lesions induced by BCG vaccination. Acta Derm Venereol. 2008, 88:621-2. 10.2340\/00015555-0496","journal-title":"Acta Derm Venereol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2019.11.003","article-title":"Art of prevention: our approach to the measles-mumps-rubella vaccine in adult patients vaccinated against measles before 1968 on biologic therapy for the treatment of psoriasis","volume":"6","author":"Worth A","year":"2020","unstructured":"Worth A, Waldman RA, Dieckhaus K, Rothe MJ. Art of prevention: our approach to the measles-mumps-rubella vaccine in adult patients vaccinated against measles before 1968 on biologic therapy for the treatment of psoriasis. Int J Womens Dermatol. 2020, 6:94-6. 10.1016\/j.ijwd.2019.11.003","journal-title":"Int J Womens Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/52638-psoriasis-to-vaccinate-or-not-to-vaccinate","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:00Z","timestamp":1707506760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/52638-psoriasis-to-vaccinate-or-not-to-vaccinate"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,23]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.15860","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,23]]}}}